跳至主要内容
临床试验/IRCT20140903019036N3
IRCT20140903019036N3招募中2 期

Comparison of efficacy and adverse effects of two chemotherapy regimens including carboplatin-paclitaxel and capecitabine-oxaliplatin in neo-adjuvant chemo-radiation of esophageal cancer for patients who were referred to Imam Khomeini cancer institute during year 95-96

Tehran University of Medical Sciences0 个研究点目标入组 92 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • Tumor should located in thoracic esophagus or gastro-esophageal junction.
  • Patients' age should be between 18-75 years old.
  • Pathology consists of squamous cell carcinoma or adenocarcinoma.
  • Tumor should be resectable.
  • Disease should be curable.

排除标准

  • Patient who suffers from bad performance status.

研究者

相似试验